drugset / Trial / NCT06322407
Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult
RandomizedParallel-groupSingle-blindTreatment
Summary
To assess the 6-months effects and safety of stellate ganglion block(SGB) for Chronic Migraine (CM) patients who failure to undergo preventive therapy and are seeking a more suitable non-pharmacological therapy.
Timeline
- Start
- 2024-06-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Ibuprofen | Small molecule | — | Oral |
| Background | Topiramate | Small molecule | 50 mg | Oral |
| Background | Topiramate | Small molecule | 100 mg | Oral |